Published in N Engl J Med on August 07, 2014
Recent US Case of Variant Creutzfeldt-Jakob Disease-Global Implications. Emerg Infect Dis (2015) 0.86
Changes in retinal function and morphology are early clinical signs of disease in cattle with bovine spongiform encephalopathy. PLoS One (2015) 0.83
Sialylation of the prion protein glycans controls prion replication rate and glycoform ratio. Sci Rep (2015) 0.82
Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease. Sci Transl Med (2016) 0.82
Grass plants bind, retain, uptake, and transport infectious prions. Cell Rep (2015) 0.77
Preclinical detection of infectivity and disease-specific PrP in blood throughout the incubation period of prion disease. Sci Rep (2015) 0.76
Guinea Pig Prion Protein Supports Rapid Propagation of Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease Prions. J Virol (2016) 0.75
Prion disease: New assays might facilitate the diagnosis of Creutzfeldt-Jakob disease in living patients. Nat Rev Neurol (2014) 0.75
2005 Donor Eligibility Requirements: Unintended Consequences for Stem Cell Development. Stem Cells Transl Med (2015) 0.75
Role of the biomarkers for the diagnosis of Creutzfeldt-Jakob disease. J Med Life (2016) 0.75
The Priority position paper: Protecting Europe's food chain from prions. Prion (2016) 0.75
Detection of prion seeding activity in the olfactory mucosa of patients with Fatal Familial Insomnia. Sci Rep (2017) 0.75
Shaken, not sonicated? N Engl J Med (2014) 0.75
CNS infections in 2014: Guns, germs, and will. Lancet Neurol (2015) 0.75
Region-specific protein misfolding cyclic amplification reproduces brain tropism of prion strains. J Biol Chem (2017) 0.75
Self-propagating, protease-resistant, recombinant prion protein conformers with or without in vivo pathogenicity. PLoS Pathog (2017) 0.75
Prions. Proc Natl Acad Sci U S A (1998) 27.80
Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature (1997) 15.73
Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature (2001) 6.20
Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet (2001) 5.57
The most infectious prion protein particles. Nature (2005) 5.37
Variant Creutzfeldt-Jakob disease. Lancet (1999) 5.17
Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet (2004) 4.85
Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet (2004) 4.59
Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci U S A (1999) 3.43
Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol (2006) 3.29
Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology (2000) 3.23
Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet (2006) 3.12
Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J Biol Chem (2006) 2.98
Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ (2013) 2.74
Prions: protein aggregation and infectious diseases. Physiol Rev (2009) 2.73
Detection of prions in blood. Nat Med (2005) 2.66
Presymptomatic detection of prions in blood. Science (2006) 2.14
Coincident scrapie infection and nephritis lead to urinary prion excretion. Science (2005) 1.94
Detection of infectious prions in urine. FEBS Lett (2008) 1.85
Urinary excretion and blood level of prions in scrapie-infected hamsters. J Gen Virol (2007) 1.66
The physical relationship between infectivity and prion protein aggregates is strain-dependent. PLoS Pathog (2010) 1.59
Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. Am J Pathol (2004) 1.56
Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-- Jakob disease: implications for human health. Proc Natl Acad Sci U S A (2001) 1.46
Estimating prion concentration in fluids and tissues by quantitative PMCA. Nat Methods (2010) 1.40
Prion hypothesis: the end of the controversy? Trends Biochem Sci (2010) 1.40
Detection of chronic wasting disease prions in salivary, urinary, and intestinal tissues of deer: potential mechanisms of prion shedding and transmission. J Virol (2011) 1.29
Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease. Am J Pathol (2006) 1.26
Diagnosing prion diseases: needs, challenges and hopes. Nat Rev Microbiol (2004) 1.25
Subclinical prion infection in humans and animals. Br Med Bull (2003) 1.25
Excretion of transmissible spongiform encephalopathy infectivity in urine. Emerg Infect Dis (2008) 1.21
Protein misfolding cyclic amplification of infectious prions. Nat Protoc (2012) 1.10
Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion disease. Philos Trans R Soc Lond B Biol Sci (2008) 1.03
Multiorgan detection and characterization of protease-resistant prion protein in a case of variant CJD examined in the United States. PLoS One (2010) 1.00
Postmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate. J Neurol Neurosurg Psychiatry (2014) 0.85
In vitro generation of infectious scrapie prions. Cell (2005) 6.86
Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study. Lancet Oncol (2007) 3.47
A prion protein epitope selective for the pathologically misfolded conformation. Nat Med (2003) 3.41
Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A (2004) 3.29
Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J Biol Chem (2006) 2.98
A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol (2008) 2.95
Prion strain mutation determined by prion protein conformational compatibility and primary structure. Science (2010) 2.71
Detection of prions in blood. Nat Med (2005) 2.66
Genetic prion disease: the EUROCJD experience. Hum Genet (2005) 2.64
Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J Biol Chem (2010) 2.57
Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. J Neurosci (2005) 2.46
Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. Ann Neurol (2004) 2.44
Newly identified prion linked to the chromatin-remodeling factor Swi1 in Saccharomyces cerevisiae. Nat Genet (2008) 2.43
Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J (2003) 2.34
A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science (2009) 2.30
Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies. Ann Neurol (2013) 2.29
Cell-free propagation of prion strains. EMBO J (2008) 2.20
Presymptomatic detection of prions in blood. Science (2006) 2.14
Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain (2009) 2.12
Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions. Cell (2008) 2.09
Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. AJNR Am J Neuroradiol (2003) 2.05
Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods Enzymol (2006) 2.04
Converting a peptide into a drug: strategies to improve stability and bioavailability. Curr Med Chem (2002) 2.02
Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis (2012) 2.01
Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. Proc Natl Acad Sci U S A (2003) 2.01
Conversion of the BASE prion strain into the BSE strain: the origin of BSE? PLoS Pathog (2007) 1.97
Accelerated high fidelity prion amplification within and across prion species barriers. PLoS Pathog (2008) 1.89
Chronic wasting disease and potential transmission to humans. Emerg Infect Dis (2004) 1.87
Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease. Ann Neurol (2011) 1.86
Isolation and characterization of a proteinase K-sensitive PrPSc fraction. Biochemistry (2006) 1.86
Detection of infectious prions in urine. FEBS Lett (2008) 1.85
Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathol (2008) 1.85
Variant CJD in an individual heterozygous for PRNP codon 129. Lancet (2009) 1.84
De novo generation of infectious prions in vitro produces a new disease phenotype. PLoS Pathog (2009) 1.83
Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. FEBS Lett (2005) 1.77
Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol (2012) 1.75
The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity. J Neurosci (2005) 1.74
Analysis of the geographical distribution of sporadic Creutzfeldt-Jakob disease in France between 1992 and 1998. Int J Epidemiol (2002) 1.70
DeltaNp63 regulates thymic development through enhanced expression of FgfR2 and Jag2. Proc Natl Acad Sci U S A (2007) 1.70
Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol (2010) 1.66
Familial and sporadic fatal insomnia. Lancet Neurol (2003) 1.65
Production of cattle lacking prion protein. Nat Biotechnol (2006) 1.63
Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology (2006) 1.61
Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease. J Biol Chem (2003) 1.61
Unfolded protein response transcription factor XBP-1 does not influence prion replication or pathogenesis. Proc Natl Acad Sci U S A (2008) 1.60
Evaluation of the human transmission risk of an atypical bovine spongiform encephalopathy prion strain. J Virol (2008) 1.59
Insoluble aggregates and protease-resistant conformers of prion protein in uninfected human brains. J Biol Chem (2006) 1.57
Intercellular transfer of the cellular prion protein. J Biol Chem (2002) 1.54
Classification of sporadic Creutzfeldt-Jakob disease revisited. Brain (2006) 1.54
Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas. Cancer Biol Ther (2006) 1.54
Progressive supranuclear palsy and Parkinson's disease in a family with a new mutation in the tau gene. Ann Neurol (2004) 1.51
Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. J Biol Chem (2004) 1.50
Stressing out the ER: a role of the unfolded protein response in prion-related disorders. Curr Mol Med (2006) 1.49
A case of dementia parkinsonism resembling progressive supranuclear palsy due to mutation in the tau protein gene. Arch Neurol (2003) 1.49
Cyclic amplification of protein misfolding and aggregation. Methods Mol Biol (2005) 1.48
beta-amyloid is different in normal aging and in Alzheimer disease. J Biol Chem (2005) 1.48
An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease. J Alzheimers Dis (2011) 1.45
Implementation of renal key performance indicators: promoting improved clinical practice. Nephrology (Carlton) (2015) 1.43
Antibody to DNA detects scrapie but not normal prion protein. Proc Natl Acad Sci U S A (2004) 1.43
Estimating prion concentration in fluids and tissues by quantitative PMCA. Nat Methods (2010) 1.40
Characterization of truncated forms of abnormal prion protein in Creutzfeldt-Jakob disease. J Biol Chem (2008) 1.40
The prion strain phenomenon: molecular basis and unprecedented features. Biochim Biophys Acta (2006) 1.39
Tetracyclines affect prion infectivity. Proc Natl Acad Sci U S A (2002) 1.39
Iatrogenic Creutzfeldt-Jakob disease in Australia: time to amend infection control measures for pituitary hormone recipients? Med J Aust (2010) 1.39
Cattle fertility problems and Histophilus somni. Vet Rec (2007) 1.39
Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc. Proc Natl Acad Sci U S A (2004) 1.37
Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease. J Biol Chem (2003) 1.34
Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases. J Neurosci (2010) 1.33
Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol (2009) 1.32
Prion protein glycosylation is not required for strain-specific neurotropism. J Virol (2009) 1.31
Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol (2012) 1.29
In vivo generation of neurotoxic prion protein: role for hsp70 in accumulation of misfolded isoforms. PLoS Genet (2009) 1.29
V180I mutation of the prion protein gene associated with atypical PrPSc glycosylation. Neurosci Lett (2006) 1.29
The role of Sse1 in the de novo formation and variant determination of the [PSI+] prion. Genetics (2007) 1.28
Amyloid formation modulates the biological activity of a bacterial protein. J Biol Chem (2005) 1.27
Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy. Eur J Cancer (2005) 1.27
Mutant prion protein expression causes motor and memory deficits and abnormal sleep patterns in a transgenic mouse model. Neuron (2008) 1.26
Misfolded protein aggregates: mechanisms, structures and potential for disease transmission. Semin Cell Dev Biol (2011) 1.25
Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years. Brain (2012) 1.24
Prominent and persistent extraneural infection in human PrP transgenic mice infected with variant CJD. PLoS One (2008) 1.24
Intraspecies transmission of BASE induces clinical dullness and amyotrophic changes. PLoS Pathog (2008) 1.23
Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study. Eur J Cancer (2006) 1.22
NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease. J Neurol (2012) 1.21
The MET oncogene is a functional marker of a glioblastoma stem cell subtype. Cancer Res (2012) 1.21
Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies. J Neurol (2009) 1.21
Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors. Cancer Chemother Pharmacol (2014) 1.20